A Summary of Research on the Henoch-Schonleinpurpura in Children

doi:10.13438/j.cnki.jdzk.2020.03.014

Abstract

Abstract:

The study of Henoch-Schonleinpurpura (HSP) in children was reviewed in terms of epidemiology, etiology and pathogenesis, clinical manifestations, auxiliary examination, diagnostic criteria, treatment methods, prognosis and follow-up. Existing studies had fully demonstrated that, the etiology and pathogenesis of HSP werenot clear, and the mechanism of immune and genetic actionstill needs to be further studied. There is lack of specific means of clinical examination, so the diagnosis of HSP in children mainly depends on the symptoms and signs. The histopathological analysis of the patients is especially important when there are rare or uncommon clinical manifestations. At present, there is no unified and specific treatment plan of HSP at home and abroad. Most of the patients with mild illness were treated symptomatically, and most of the patients with severe illness were treated individually with hormone. However, large sample size, multi-center Randomized Controlled Trial (RTC) studies, and evidence-based medical validation are needed for relevant treatment plan of HSP. The short-term prognosis of HSP is better, and the long-term prognosis is mainly related to renal involvement. The key to reduce renal involvement lies in early detection, early diagnosis and early treatment.

Key words: hench-schonleinpurpura, immune disease, children

TAN Qiliang, MEI Shuaihu, LIU Quane, ZHOU Chu, LUO Xuemei. A Summary of Research on the Henoch-Schonleinpurpura in Children[J]. Journal of Jishou University（Natural Sciences Edition), DOI: 10.13438/j.cnki.jdzk.2020.03.014.

References

[1] BARUT K, SAHIN S, KASAPCOPUR O. Pediatric Vasculitis[J]. Curr Opin Rheumatol, 2016, 28(1): 29-38.
[2] YAO-HSU Y, HSIN-HUI Y, BOR-LUEN C. The Diagnosis and Classification of Henoch-Schnlein Purpura: An Updated Review[J]. Autoimmunity Reviews, 2014, 13(4/5): 355-358.
[3] CHEN O, ZHU X B, REN P, et al. Henoch Schonlein Purpura in Children: Clinical Analysis of 120 Cases[J]. African Health Sciences, 2013, 13(1): 94-99.
[4] TRAPANI S, MICHELI A, GRISOLIA F, et al. Henoch Schonlein Purpura in Childhood: Epidemiological and Clinical Analysis of 150 Cases Over a 5-year Period and Review of Literature[J]. Seminars in Arthritis and Rheumatism, 2005, 35(3): 143-153.
[5] JOOST A, KOERD D, GRACITA R, et al. Henoch Schonlein Purpura in Children: An Epidemiological Study Among Dutch Paediatricians on Incidence and Diagnostic Criteria[J]. Annals of the Rheumatic Diseases, 2007, 66(12): 1648-1650.
[6] YANG Y H, HUNG C F, HSU C R, et al. A Nationwide Survey on Epidemiological Characteristics of Childhood Henoch-Schonlein Purpura in Taiwan[J]. Rheumatology, 2005, 44(5): 618-622.
[7] 郑敏，潘雪娇，谭祥永，等.江西省儿童过敏性紫癜住院病例发病情况调查[J].现代预防医学，2013，40(10):1865-1868.
[8] WANG Xuehong, ZHU Yongmei, GAO Laiqiang, et al. Henoch-Schnlein Purpura with Joint Involvement: Analysis of 71 Cases[J]. Pediatric Rheumatology, 2016, 14(1): 13-20.
[9] CALVO-RIO V, HERNANDEZ J L, ORTIZ-SANJUAN F, et al. Relapses in Patients with Henoch-Schnlein Purpura[J]. Medicine, 2016, 95(28): e4217.
[10] LEI W T, TSAI P L, CHU S H, et al. Incidence and Risk Factors for Recurrent Henoch-Schnlein Purpura in Children from a 16-Year Nationwide Database[J]. Pediatric Rheumatology, 2018, 16(1): 16-25.
[11] OUTI J, JAANA R, OLLI K, et al. Renal Manifestations of Henoch-Schonlein Purpura in a 6-Month Prospective Study of 223 Children[J]. Archives of Disease in Childhood, 2010, 95(11): 877-882.
[12] WEISS P F, KLINK A J, LUAN X Q, et al. Temporal Association of Streptococcus, Staphylococcus, and Parainfluenza Pediatric Hospitalizations and Hospitalized Cases of Henoch-Schnlein Purpura[J]. Journal of Rheumatology, 2010, 37(12): 2587-2594.
[13] WATANABE T. Henoch-Schnlein Purpura Following Influenza Vaccinations During the Pandemic of Influenza A(H1N1)[J]. Pediatric Nephrology, 2011, 26(5): 795-798.
[14] ZAFRIR Y, AGMON-LEVIN N, SHOENFELD Y. Post-Influenza Vaccination Vasculitides: A Possible New Entity[J]. JCR: Journal of Clinical Rheumatology, 2009, 15(6): 269-270.
[15] RIGANTE D, CASTELLAZZI L, BOSCO A, et al. Is There a Crossroad Between Infections, Genetics, and Henoch-Schnlein Purpura?[J]. Autoimmunity Reviews, 2013, 12(10): 1016-1021.
[16] LOPEZ-MEJIAS R, GENRE F, PEREZ B S, et al. HLA-DRB1 Association with Henoch-Schonlein Purpura[J]. Arthritis & Rheumatology, 2015, 67(3): 823-827.
[17] SALAH S, RIZK S, LOTFY H M, et al. MEFV Gene Mutations in Egyptian Children with Henoch-Schonlein Purpura[J]. Pediatric Rheumatology, 2014, 12(1): 87-89.
[18] JIANG Jue, DUAN Wuqiong, SHANG Xu, et al. Inducible Nitric Oxide Synthase Gene Polymorphisms are Associated with a Risk of Nephritis in Henoch-Schnlein Purpura Children[J]. European Journal of Pediatrics, 2017, 176(8): 1035-1045.
[19] XU Hui, JIANG Guizhen, SHEN Hongqiang, et al. Association of TLR4 Gene Polymorphisms with Childhood Henoch-Schnlein Purpura in a Chinese Population[J]. Rheumatology International, 2017, 37(11): 1909-1915.
[20] HSIN-HUI Y, PI-HUA L, YAO-HSU Y, et al. Chemokine MCP1/CCL2 and RANTES/CCL5 Gene Polymorphisms Influence Henoch-Schonlein Purpura Susceptibility and Severity[J]. Journal of the Formosan Medical Association, 2015, 114(4): 347-352.
[21] XU Hui, PAN Yanxiang, LI Wei, et al. Association Between IL17A and IL17F Polymorphisms and Risk of Henoch-Schonlein Purpura in Chinese Children[J]. Rheumatology International, 2016, 36(6): 829-835.
[22] DING Guixia, WANG Chenhu, CHE Ruochen, et al. Heat Shock Protein 70-2 and Tumor Necrosis Factor-α Gene Polymorphisms in Chinese Children with Henoch-Schnlein Purpura[J]. World Journal of Pediatrics, 2016, 12(1): 49-54.
[23] SAULSBURY F T. Henoch-Schnlein Purpura[J]. Curr Opin Rheumatol, 2010, 22(5): 598-602.
[24] 张红，王强，房俊，等.儿童过敏性紫癜急性期T细胞亚群及B细胞的变化及意义[J].实用医院临床杂志，2017，14(2):75-77.
[25] LIN Qiang, LI Xiaozhong. Children with Henoch-Schnlein Purpura with Low Complement Levels: Follow-up for >6 Years[J]. Pediatric Nephrology, 2017, 32(7): 1279-1279.
[26] HE Xuelian, YIN Wei, DING Yan, et al. Higher Serum Angiotensinogen is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis[J]. PLoS ONE, 2015, 10(6): e013536.
[27] ZHANG Fanhui, CHEN Lihua, SHANG Shiqiang, et al. Atypical Purpura Location in a Pediatric Patient with Henoch-Schnlein Purpura: A Case Report[J]. Medicine, 2018, 97(48): e13294.
[28] RAMELLI V, LAVA S A G, SIMONETTI G D, et al. Blistering Eruptions in Childhood Henoch-Schnlein Syndrome: Systematic Review of the Literature[J]. European Journal of Pediatrics, 2017, 176(4): 487-492.
[29] TRAPANI S, MARRIOTTI P, RESTI M, et al. Severe Hemorrhagic Bullous Lesions in Henoch Schonlein Purpura: Three Pediatric Cases and Review of the Literature[J]. Rheumatology International, 2010, 30(10): 1355-1359.
[30] OZEN S, PISTORIO A, IUSAN S M, et al. EULAR/PRINTO/PRES Criteria for Henoch-Schnlein Purpura, Childhood Polyarteritis Nodosa, Childhood Wegener Granulomatosis and Childhood Takayasu Arteritis: Ankara 2008. Part II: Final Classification Criteria[J]. Annals of the Rheumatic Diseases, 2010, 69(5): 798-806.
[31] BUTSABONG L, SUPORN T, PAWAREE S, et al. Henoch-Schnlein Purpura from Vasculitis to Intestinal Perforation: A Case Report and Literature Review[J]. World Journal of Gastroenterology, 2016, 22(26): 6089-6094.
[32] XIA Yonghui, MAO Jianhua, CHEN Yifang, et al. Clinical Outcomes in Children with Henoch-Schnlein Purpura Nephritis Grade IIIa or IIIb[J]. Pediatric Nephrology, 2011, 26(7): 1083-1088.
[33] YOON K, JIN-SU P, YOU-JUNG H, et al. Differences in Clinical Manifestations and Outcomes Between Adult and Child Patients with Henoch-Schnlein Purpura[J]. Journal of Korean Medical Science, 2014, 29(2): 198-203.
[34] SANTOS D D, LANGER F W, SANTOS T D, et al. Posterior Reversible Encephalopathy Syndrome as a Complication of Henoch-Schnlein Purpura in a Seven-Year-Old Girl[J]. Scottish Medical Journal, 2017, 62(1): 34-37.
[35] CHAN Han, TANG Yanling, LV Xiahang, et al. Risk Factors Associated with Renal Involvement in Childhood Henoch-Schnlein Purpura: A Meta-Analysis[J]. PLoS ONE, 2016, 11(11): e0167346.
[36] COHEN N, MIMOUNI F B, FRIEDEL N, et al. Predictors of Hospital Length of Stay in Pediatric Henoch-Schnlein Purpura[J]. Rheumatology International, 2015, 35(9): 1561-1564.
[37] CHEN Tao, LU Yonghong, WANG Wenju, et al. Elevated Urinary Levels of Cystatin C and Neutrophil Gelatinase-Associated Lipocalin in Henoch-Schonlein Purpura Patients with Renal Involvement[J]. PLoS ONE, 2017, 9(6): e101026.
[38] BARTYNSKI W S. Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features[J]. American Journal of Neuroradiology, 2008, 29(6): 1036-1042.
[39] OZEN S, RUPERTO N, DILLON M J, et al. EULAR/PReS Endorsed Consensus Criteria for the Classification of Childhood Vasculitides[J]. Annals of the Rheumatic Diseases, 2006, 65(7): 936-941.
[40] 吴小川，唐雪梅，胡坚，等.儿童过敏性紫癜循证诊治建议[J].中华儿科杂志，2013，51(7):502-507.
[41] KAMAL M, YOSEPH H, AVI A, et al. Establishing Hospital Admission Criteria of Pediatric Henoch-Schonlein Purpura[J]. Rheumatology International, 2014, 34(11): 1497-1503.
[42] HERNSTADT H M, BARTLETT M, KAUSMAN J Y, et al. Complicated Henoch-Schnlein Purpura[J]. Journal of Paediatrics and Child Health, 2015, 51(6): 639-642.
[43] WEISS P F, FEINSTEIN J A, LUAN X Q, et al. Effects of Corticosteroid on Henoch-Schnlein Purpura: A Systematic Review[J]. Pediatrics, 2007, 120(5): 1079-1087.
[44] ZHAO Yongli, LIU Zhengjuan, BAI Xuemei, et al. Obesity Increases the Risk of Renal Involvement in Children with Henoch-Schnlein Purpura[J]. European Journal of Pediatrics, 2015, 174(10): 1357-1363.
[45] NARCHI H. Risk of Long Term Renal Impairment and Duration of Follow up Recommended for Henoch-Schonlein Purpura with Normal or Minimal Urinary Findings: A Systematic Review[J]. Archives of Disease in Childhood, 2005, 90(9): 916-920.